Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Labcorp Holdings Inc. before investing.

In this article, we go over a few key elements for understanding Labcorp Holdings Inc.’s stock price such as:

• Labcorp Holdings Inc.’s current stock price and volume
• Why Labcorp Holdings Inc.’s stock price changed recently
• Upgrades and downgrades for LH from analysts
• LH’s stock price momentum as measured by its relative strength

About Labcorp Holdings Inc. (LH)

Before we jump into Labcorp Holdings Inc.’s stock price, history, target price and what caused it to recently dip, let’s take a look at some background.

Labcorp Holdings Inc. provides laboratory services. It operates in Diagnostics Laboratories and Biopharma Laboratory Services segments. The company offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, PAP tests, hemoglobin A1C, PSA, tests for sexually transmitted diseases, vitamin D testing, microbiology cultures and procedures, and alcohol and other substance abuse tests. It also provides specialty testing services comprising gene-based and esoteric testing; advanced tests target specific diseases; services related to anatomic pathology/oncology, cardiovascular disease, coagulation, diagnostic genetics, endocrinology, infectious disease, women's health, pharmacogenetics, parentage and donor testing, occupational testing service, medical drug monitoring services, chronic disease programs, and kidney stone prevention tests; and health and wellness services to employers and managed care organizations. In addition, it offers digital pathology solutions, a pathology platforms that support the digitization, centralized review, and sharing of pathology slides; provider and payer digital platforms, an online applications for providers, MCOs, and ACOs; online and mobile applications that enable patients to check offerings, schedule PSC visits, check-in upon PSC arrival, complete documentation, access tests and test results, and manage their accounts; and Generative AI enabled Test Selection, a generative AI enabled tool. It serves clients, third party, medicare/medicaid, patients, pharmaceutical, biotechnology, medical device, diagnostic companies, and CROs. It has a strategic collaboration with the Children's Hospital of Philadelphia to accelerate the discovery, development, and availability of pediatric diagnostics; and Alliance for Clinical Trials in Oncology to advance national clinical trial for patients diagnosed with colorectal cancer. The company was founded in 1995 and is headquartered in Burlington, North Carolina.

Want to learn more about Labcorp Holdings Inc.’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Labcorp Holdings Inc..

Labcorp Holdings Inc.’s Stock Price as of Market Close

As of July 31, 2026, 4:00 PM, CST, Labcorp Holdings Inc.’s stock price was $309.200.

Labcorp Holdings Inc. is down 2.01% from its previous closing price of $315.530.

During the last market session, Labcorp Holdings Inc.’s stock traded between $305.060 and $314.820. Currently, there are approximately 82.30 million shares outstanding for Labcorp Holdings Inc..

Labcorp Holdings Inc.’s price-earnings (P/E) ratio is currently at 27.4, which is high compared to the Health Care Providers & Services industry median of 26.7. The price-earnings ratio gauges market expectation of future performance by relating a stock’s current share price to its earnings per share.

Labcorp Holdings Inc. Stock Price History

Labcorp Holdings Inc.’s (LH) price is currently up 10.43% so far this month.

During the month of July, Labcorp Holdings Inc.’s stock price has reached a high of $316.110 and a low of $262.105.

Over the last year, Labcorp Holdings Inc. has hit prices as high as $316.110 and as low as $244.520. Year to date, Labcorp Holdings Inc.’s stock is up 23.25%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused Labcorp Holdings Inc. Stock’s Price to Dip?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of July 31, 2026, there was 1 analyst who downgraded Labcorp Holdings Inc.’s stock and 1 analyst who upgraded over the last month.

Additionally, you'll want to evaluate Labcorp Holdings Inc.’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on Labcorp Holdings Inc.’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Labcorp Holdings Inc.’s current valuation based on AAII’s Value Grade is a D, which means it is considered to be Expensive.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Labcorp Holdings Inc. (LH) by visiting AAII Stock Evaluator.

Relative Price Strength of Labcorp Holdings Inc.

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of July 31, 2026, Labcorp Holdings Inc. has a weighted four-quarter relative price strength of 4.03%, which translates to a Momentum Score of 67 and is considered to be Strong.

Want to learn more about how Labcorp Holdings Inc. is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

Labcorp Holdings Inc. Stock Price: Bottom Line

As of July 31, 2026, Labcorp Holdings Inc.’s stock price is $309.200, which is down 2.01% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like Labcorp Holdings Inc. stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.